CVD prevention, treatment challenging as patients with HIV, HCV live longer

"The prevalence of smoking in people with HIV infection is 60% to 80% in some studies, which is much higher than in the general population," Chris T. Longenecker, MD, assistant professor of medicine and director of an HIV cardiometabolic risk clinic at Case Western Reserve University in Cleveland, told Infectious Disease News. [...]that thinking is changing, especially in light of the introduction of new ART that do not appear to be associated with increased CV risk, Grinspoon said.\n Researchers also will study the safety of statin therapy and its impact on cholesterol levels, immunologic parameters and serious non-CVD events such as new-onset diabetes, according to the NIH.